Saturday, September 18, 2021

Merck, Johnson & Johnson to strike ‘wartime’ COVID-19 vaccine manufacturing deal: WaPo

Merck & Co., a leading vaccine player worldwide, has been largely absent during the COVID-19 vaccine race. Not anymore: The drugmaker is set to partner with Johnson & Johnson to boost production of its newly authorized shot, the Washington Post reports.

President Joe Biden is set to unveil the deal Tuesday, the newspaper reports. During the first days of his administration, officials realized J&J had fallen behind on production targets, so officials jumped in to coordinate a tie-up between the companies.

Recognizing it’s a “wartime effort,” the companies agreed to join forces when they might otherwise be rivals, one unnamed official told the newspaper.


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.

Merck will provide access to two U.S. manufacturing sites—one where workers will make the actual vaccine substance, and another where it will be filled into vials and packaged for shipping. The partnership could potentially double J&J’s expected vaccine capacity, officials said.

A Merck spokesman said the company “remains steadfast in our commitment to contribute to the global response to the pandemic and to preparing to address future pandemics.” He didn’t confirm or deny the WaPo’s reporting.

RELATED: Johnson & Johnson’s COVID-19 vaccine scores FDA authorization, adding key third shot to U.S. supply

News of the tie-up comes right after the J&J vaccine won emergency use authorization from the FDA. For Merck, it follows an embarrassing exit from the COVID-19 vaccine race after early-stage programs posted disappointing data.

After Johnson & Johnson’s vaccine authorization over the weekend, CEO Alex Gorsky told Bloomberg the company was “leaving no stone unturned” in its efforts to boost production. J&J has said it would have around 4 million doses to ship at launch, plus 20 million in total this month and 100 million by the end of June.

Still, the company is “doing everything we can partnering with the U.S. government and other external manufacturers to see what we can do to accelerate and increase that number as well,” Gorsky told Bloomberg.

RELATED: Merck canned its own COVID-19 vaccines. Now, it’s in talks to manufacture other companies’ shots

Merck has been teasing potential manufacturing tie-ups as well. Several weeks ago, a spokesman said the company was “actively involved” in discussions with governments, health agencies and other pharmaceutical companies to “identify the areas of pandemic response where we can play a role, including potential support for production of authorized vaccines.”

But don’t expect an immediate boost in supply from the partnership. It’ll likely take months to get the sites up and running to start churning out new doses.

The drug giants won’t be the only Big Pharma companies to team up to fight the pandemic. J&J has already enlisted Sanofi to help with vaccine production in Europe, while Pfizer and BioNTech have unveiled partnerships with Sanofi and Novartis.

On the antibody side of the fight, Roche and Regeneron have joined forces to boost capacity, as have Amgen and Eli Lilly.

Source link

Latest Articles

Personal Selling

INTRODUCTION Early sellers and traders were not held in high esteem. The Roman word for salesman meant ‘Cheater’ and...

Building Muscle on a Vegan Diet

There are a lot of  misconceptions surrounding veganism. The notion that those who practice it are lacking in protein and therefore muscles is the...

Electrodes in brain new hope for severe cases of epilepsy

Neurosurgeons at All India Institute of Medical Sciences have devised a new technique for operating on children suffering from a severe form of epilepsy...

Understand Key Account Management

INTRODUCTION: Key Account Management is the essential showcasing approach that gives a successful, useful, and rather basic technique for...

Need to create vigilance and awareness on zoonotic diseases: India’s Health Minister

The COVID-19 pandemic has highlighted the need of creating vigilance and awareness on zoonotic diseases, informed Union Health Minister Mansukh Mandaviya while virtually inaugurating...